Company Quest Laboratories Limited

QUESTLAB

INE0TNW01017

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 12:05:09 29/07/2026 BST			5-day change	1st Jan Change
95.00 ^INR	+5.56%		+2.21%	-13.71%

02-12	Quest Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-12	Quest Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

Business description: Quest Laboratories Limited

Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.

Number of employees: 50

Sales by Activity: Quest Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Drugs And Chemicals	304M	595M	616M	826M	1.04B

See all business segments

Geographical breakdown of sales: Quest Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
India	304M	595M	616M	826M	1.04B

See all geographic segments

Executive Committee: Quest Laboratories Limited

Manager	Title	Age	Since
Anil Kumar Sabarwal CEO	Chief Executive Officer	59	31/12/2023
Ramkrishna Sharma DFI	Director of Finance/CFO	38	31/12/2023
Ayushi Taunk CMP	Compliance Officer	-	02/09/2025
Gopal Krishan PRN	Corporate Officer/Principal	54	30/06/2015

See QUEST LABORATORIES LIMITED governance

Composition of the Board of Directors: Quest Laboratories Limited

Director	Title	Age	Since
Anil Kumar Sabarwal CHM	Chairman	59	31/12/2023
Tejaswini Sabarwal BRD	Director/Board Member	30	04/03/2021
Gautam Chand Kothari BRD	Director/Board Member	72	09/01/2024
Amit Ramesh Chandak BRD	Director/Board Member	42	09/01/2024
Basant Lal Menghwani BRD	Director/Board Member	71	09/01/2024
Umendra Suthar BRD	Director/Board Member	-	30/06/2024
Vinayak Sabarwal BRD	Director/Board Member	-	30/06/2024

Composition of the Board of Directors

Company details: Quest Laboratories Limited

Quest Laboratories Pvt Ltd.

Plot No. 45

454775, Dhar

+91 72 9229 2374

http://www.questlabltd.com

address Quest Laboratories Limited(QUESTLAB)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
QUEST LABORATORIES LIMITED	+5.56%	+2.21%	-10.12%	-	16.25M
ELI LILLY AND COMPANY	-0.87%	+4.04%	+58.60%	+163.92%	1,079B
JOHNSON & JOHNSON	-0.45%	+3.87%	+57.95%	+52.18%	640B
ABBVIE INC.	+0.04%	+3.95%	+37.69%	+74.54%	465B
ROCHE HOLDING AG	-1.69%	+8.81%	+39.38%	+34.26%	353B
NOVARTIS AG	-0.51%	+3.51%	+36.97%	+43.76%	301B
ASTRAZENECA PLC	+1.50%	+3.40%	+17.71%	+18.77%	271B
NOVO NORDISK A/S	+0.79%	+5.81%	-2.55%	-36.02%	228B
AMGEN INC.	-1.39%	+5.90%	+27.70%	+64.00%	209B
GILEAD SCIENCES, INC.	-1.18%	+1.83%	+16.20%	+72.69%	165B
Average	+0.18%	+4.76%	+27.95%	+54.23%	370.97B
Weighted average by Cap.	-0.50%	+5.04%	+41.92%	+78.83%